If you're not immune to measles you can catch it just by going into a room up to 2 hours after an infected person has left it!
Vaccines are a key component of global health policy and are essential in the defence of the health of young children. Our research focuses on the development and evaluation of new and improved vaccines.Explore
Events and Training
We are committed to providing high quality education and training, together with research updates for medical professionals and all those involved in the area of vaccines and paediatric and adult infectious diseases.Learn
There are a number of ways in which you can get involved in our research, inform our research and find out more about our work. To find out more about any of these options, follow the link below.
A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
Marlow R. et al, (2018), Vaccine
Antenatal vaccination against Group B streptococcus: attitudes of pregnant women and healthcare professionals in the UK towards participation in clinical trials and routine implementation.
McQuaid F. et al, (2018), Acta Obstet Gynecol Scand, 97, 330 - 340
Management of suspected paediatric meningitis: a multicentre prospective cohort study.
Ramasamy R. et al, (2018), Archives of disease in childhood